Skip to main content

ENGERIX-B

NDC 50090-1223 · A-S Medication Solutions

Generic nameHepatitis B Vaccine (Recombinant)
Dosage formINJECTION, SUSPENSION
RouteINTRAMUSCULAR
Active ingredient(s)HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN
Strength20 ug/mL
Marketing categoryBLA

Packages

50090-1223-1 — 1 VIAL, SINGLE-DOSE in 1 POUCH (50090-1223-1) / 1 mL in 1 VIAL, SINGLE-DOSE

50090-1223-2 — 10 VIAL, SINGLE-DOSE in 1 CARTON (50090-1223-2) / 1 mL in 1 VIAL, SINGLE-DOSE (50090-1223-0)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50090-1645 — Hepatitis A and Hepatitis B (Recombinant) Vaccine, 58160-815 — Hepatitis A and Hepatitis B (Recombinant) Vaccine, 58160-820 — Hepatitis B Vaccine (Recombinant), 58160-821 — Hepatitis B Vaccine (Recombinant)

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels